Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed.

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...

The city of Greensboro has joined a national litigation campaign suing the nation's three largest pharmacy benefit managers and three largest insulin manufacturers with the goal of lowering insulin pr ...

The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...

For those who want to use semaglutide to lose weight without having diabetes, the drug of choice is Wegovy. In a sense, we could compare Eli Lilly's Mounjaro to Novo Nordisk's Ozempic/Rybelsus ...

Eli Lilly (LLY 1.45%) began a roll in late 2020 that lasted almost four years. During that time, it became the world's ...

Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...

“The Federal Trade Commission recently alleged that the insulin industry ... Court of Maryland against Eli Lilly and 17 other companies, including CVS and Novo Nordisk. The lawsuit alleges ...

Columbus joins the states of Arkansas, California, Kansas, Kentucky, Minnesota and Mississippi and other cities and counties ...

Novo's Ozempic is approved by the U.S. Food and Drug Administration (FDA) to treat diabetes, while Wegovy is primarily prescribed for obesity care. In the same vein, Lilly's Mounjaro is approved ...

The company said it overestimated demand of its obesity and diabetes drugs in the fourth quarter, but projected a further ...